Freedom of Information
- Title
- Intra-vitreal injections or implants
- Reference Number
- RF24-038
- Request Details
Could you please tell me how many of the following intra-vitreal injections/implants has your Trust administered in the four-month period from September to December 2023:
• Aflibercept
• Bevacizumab - Avastin
• Bevacizumab - Biosimilar
• Brolucizumab
• Dexamethasone
• Faricimab
• Fluocinolone acetonide
• Ranibizumab - Lucentis (pre-filled syringes)
• Ranibizumab - Lucentis (vials)
• Ranibizumab - Ongavia
- Response
-
- rf24-038-response.pdf
- Date of Disclosure
- 08/02/2024